STELLANTIS NV (STLA) Fundamental Analysis & Valuation

NYSE:STLA • NL00150001Q9

Current stock price

8.06 USD
-0.23 (-2.77%)
At close:
8.06 USD
0 (0%)
After Hours:

This STLA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. STLA Profitability Analysis

1.1 Basic Checks

  • STLA had positive earnings in the past year.
  • STLA had a negative operating cash flow in the past year.
  • STLA had positive earnings in 4 of the past 5 years.
  • STLA had a positive operating cash flow in 4 of the past 5 years.
STLA Yearly Net Income VS EBIT VS OCF VS FCFSTLA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10B -10B 20B -20B

1.2 Ratios

  • STLA has a better Return On Assets (-1.19%) than 68.57% of its industry peers.
  • STLA's Return On Equity of -3.27% is fine compared to the rest of the industry. STLA outperforms 71.43% of its industry peers.
Industry RankSector Rank
ROA -1.19%
ROE -3.27%
ROIC N/A
ROA(3y)0.12%
ROA(5y)3.53%
ROE(3y)-4.1%
ROE(5y)7.28%
ROIC(3y)N/A
ROIC(5y)N/A
STLA Yearly ROA, ROE, ROICSTLA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 -40

1.3 Margins

  • Looking at the Gross Margin, with a value of 7.74%, STLA is in line with its industry, outperforming 57.14% of the companies in the same industry.
  • STLA's Gross Margin has declined in the last couple of years.
  • STLA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 7.74%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-66.41%
GM growth 5Y-43.81%
STLA Yearly Profit, Operating, Gross MarginsSTLA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. STLA Health Analysis

2.1 Basic Checks

  • STLA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, STLA has more shares outstanding
  • STLA has more shares outstanding than it did 5 years ago.
  • STLA has a worse debt/assets ratio than last year.
STLA Yearly Shares OutstandingSTLA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B
STLA Yearly Total Debt VS Total AssetsSTLA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50B 100B 150B 200B

2.2 Solvency

  • STLA has an Altman-Z score of 1.32. This is a bad value and indicates that STLA is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of STLA (1.32) is better than 68.57% of its industry peers.
  • A Debt/Equity ratio of 0.38 indicates that STLA is not too dependend on debt financing.
  • The Debt to Equity ratio of STLA (0.38) is better than 68.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Altman-Z 1.32
ROIC/WACCN/A
WACC6.87%
STLA Yearly LT Debt VS Equity VS FCFSTLA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20B 40B 60B 80B

2.3 Liquidity

  • A Current Ratio of 1.06 indicates that STLA should not have too much problems paying its short term obligations.
  • STLA has a Current ratio of 1.06. This is in the lower half of the industry: STLA underperforms 62.86% of its industry peers.
  • A Quick Ratio of 0.77 indicates that STLA may have some problems paying its short term obligations.
  • STLA has a Quick ratio (0.77) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.06
Quick Ratio 0.77
STLA Yearly Current Assets VS Current LiabilitesSTLA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. STLA Growth Analysis

3.1 Past

  • STLA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -16.56%.
  • Measured over the past years, STLA shows a very strong growth in Earnings Per Share. The EPS has been growing by 31.54% on average per year.
  • STLA shows a decrease in Revenue. In the last year, the revenue decreased by -2.15%.
  • STLA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.93% yearly.
EPS 1Y (TTM)-16.56%
EPS 3Y32%
EPS 5Y31.54%
EPS Q2Q%-13142.94%
Revenue 1Y (TTM)-2.15%
Revenue growth 3Y0.75%
Revenue growth 5Y2.93%
Sales Q2Q%8.07%

3.2 Future

  • Based on estimates for the next years, STLA will show a decrease in Earnings Per Share. The EPS will decrease by -3.15% on average per year.
  • The Revenue is expected to grow by 7.56% on average over the next years.
EPS Next Y-62.6%
EPS Next 2Y18.5%
EPS Next 3Y27.09%
EPS Next 5Y-3.15%
Revenue Next Year25.31%
Revenue Next 2Y17.08%
Revenue Next 3Y17.94%
Revenue Next 5Y7.56%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
STLA Yearly Revenue VS EstimatesSTLA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 50B 100B 150B 200B
STLA Yearly EPS VS EstimatesSTLA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 2 -2 4 6

More info and screens

Find the best growth stocksShow best growing peers

6

4. STLA Valuation Analysis

4.1 Price/Earnings Ratio

  • STLA is valuated cheaply with a Price/Earnings ratio of 2.58.
  • Compared to the rest of the industry, the Price/Earnings ratio of STLA indicates a rather cheap valuation: STLA is cheaper than 100.00% of the companies listed in the same industry.
  • When comparing the Price/Earnings ratio of STLA to the average of the S&P500 Index (27.42), we can say STLA is valued rather cheaply.
  • Based on the Price/Forward Earnings ratio of 1.84, the valuation of STLA can be described as very cheap.
  • STLA's Price/Forward Earnings ratio is rather cheap when compared to the industry. STLA is cheaper than 100.00% of the companies in the same industry.
  • STLA's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.29.
Industry RankSector Rank
PE 2.58
Fwd PE 1.84
STLA Price Earnings VS Forward Price EarningsSTLA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, STLA is valued cheaper than 94.29% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 5.59
STLA Per share dataSTLA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

  • A more expensive valuation may be justified as STLA's earnings are expected to grow with 27.09% in the coming years.
PEG (NY)N/A
PEG (5Y)0.08
EPS Next 2Y18.5%
EPS Next 3Y27.09%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. STLA Dividend Analysis

5.1 Amount

  • STLA does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

STLA Fundamentals: All Metrics, Ratios and Statistics

STELLANTIS NV

NYSE:STLA (4/24/2026, 8:09:42 PM)

After market: 8.06 0 (0%)

8.06

-0.23 (-2.77%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobiles
Earnings (Last)02-26
Earnings (Next)04-30
Inst Owners48.42%
Inst Owner Change0.13%
Ins Owners0.12%
Ins Owner ChangeN/A
Market Cap23.40B
Revenue(TTM)153.51B
Net Income(TTM)-2.39B
Analysts69.44
Price Target9.39 (16.5%)
Short Float %3.12%
Short Ratio3.07
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0.79
Dividend Growth(5Y)N/A
DP-81.93%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-5.35%
PT rev (3m)-18.25%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-10.97%
EPS NY rev (3m)-45.82%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.23%
Revenue NY rev (3m)-0.75%
Valuation
Industry RankSector Rank
PE 2.58
Fwd PE 1.84
P/S 0.14
P/FCF N/A
P/OCF N/A
P/B 0.27
P/tB 0.86
EV/EBITDA 5.59
EPS(TTM)3.13
EY38.83%
EPS(NY)4.39
Fwd EY54.48%
FCF(TTM)-6.47
FCFYN/A
OCF(TTM)-2.22
OCFYN/A
SpS58.94
BVpS29.49
TBVpS9.41
PEG (NY)N/A
PEG (5Y)0.08
Graham Number45.5733 (465.43%)
Profitability
Industry RankSector Rank
ROA -1.19%
ROE -3.27%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 7.74%
FCFM N/A
ROA(3y)0.12%
ROA(5y)3.53%
ROE(3y)-4.1%
ROE(5y)7.28%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-66.41%
GM growth 5Y-43.81%
F-Score1
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Debt/EBITDA 5.91
Cap/Depr 145.84%
Cap/Sales 7.2%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.06
Quick Ratio 0.77
Altman-Z 1.32
F-Score1
WACC6.87%
ROIC/WACCN/A
Cap/Depr(3y)139.68%
Cap/Depr(5y)144.78%
Cap/Sales(3y)6.13%
Cap/Sales(5y)6.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-16.56%
EPS 3Y32%
EPS 5Y31.54%
EPS Q2Q%-13142.94%
EPS Next Y-62.6%
EPS Next 2Y18.5%
EPS Next 3Y27.09%
EPS Next 5Y-3.15%
Revenue 1Y (TTM)-2.15%
Revenue growth 3Y0.75%
Revenue growth 5Y2.93%
Sales Q2Q%8.07%
Revenue Next Year25.31%
Revenue Next 2Y17.08%
Revenue Next 3Y17.94%
Revenue Next 5Y7.56%
EBIT growth 1Y-114.76%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1001.53%
EBIT Next 3Y150.48%
EBIT Next 5Y75.26%
FCF growth 1Y-767.64%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-139.82%
OCF growth 3YN/A
OCF growth 5YN/A

STELLANTIS NV / STLA Fundamental Analysis FAQ

What is the fundamental rating for STLA stock?

ChartMill assigns a fundamental rating of 3 / 10 to STLA.


What is the valuation status of STELLANTIS NV (STLA) stock?

ChartMill assigns a valuation rating of 6 / 10 to STELLANTIS NV (STLA). This can be considered as Fairly Valued.


What is the profitability of STLA stock?

STELLANTIS NV (STLA) has a profitability rating of 3 / 10.


What is the financial health of STELLANTIS NV (STLA) stock?

The financial health rating of STELLANTIS NV (STLA) is 2 / 10.


Can you provide the expected EPS growth for STLA stock?

The Earnings per Share (EPS) of STELLANTIS NV (STLA) is expected to decline by -62.6% in the next year.